Here's everything you need to know about VALORANT Masters Bangkok 2025, from teams, the schedule, format and much more.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Here's everything to know about the 2025 VALORANT Challengers NA season including its schedule, key info, teams and more. VALORANT Challengers NA 2025 will bring the best North American teams ...

If there is one thing that VALORANT fans don’t like to happen to them, it’s to lose their rank. This is called De-ranking in VALORANT. It simply means to fall from a given rank to the one lower to it.

Give these settings for your graphics, mouse, and crosshair a try if you want to copy how florescent plays VALORANT! Ava "florescent" Eugene is a household name these days. She is a world champion on ...

Valorant update 1.000.027 introduces Rank Shields to Competitive Mode for Tier 1 players. Rank Shields can only be replenished upon promotion or demotion to Tier 1. The update fixes several bugs ...

Agent Raze is one of a handful of characters players can choose in Valorant, and here are ten useful tips for playing as her. In addition, a well-seasoned Raze player can move more fluidly and ...

If you, on the verge of a rank demotion, have often found yourself contemplating whether to queue for another VALORANT match or just stop for the day, the latest patch finally lets you bid ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

With the Lunar New Year just around the corner, Riot Games has shed light on a new skin bundle coming to Valorant to celebrate the Year of the Snake. The new Helix skin bundle promises to be a ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...